Close Menu
    Facebook X (Twitter) Instagram
    Trending
    • NVIDIA’s AI Crown Faces Challengers, Not A Collapse
    • AI’s Biggest Battle Is No Longer the Model—It’s the Machine
    • Shaping Legacy with Strategic Mastery: IIM Calcutta Launches 8th Batch of Family Business Management to Groom Next-Gen Leaders
    • How Visionary CEO Ketan Dave is Steering Mr. Idli Toward an Historic IPO and Global Dominance
    • IHH FutureHealth.Now 2026 Explores How Affordability, AI, and Precision Medicine Will Shape the Future of Care
    • PRSI Ahmedabad to Host National Conference on ‘Fact-Checking in the Age of AI’ on July 18
    • Fluitron Technology Supports India’s First Hydrogen-Powered Train Through Hydrogen Refuelling Infrastructure
    • Gandaram Jewellers Opens Flagship Store in Noida Sector 18, Bringing Certified Diamond Engagement Rings and Luxury Bridal Jewellery Closer to Delhi NCR Customers
    Republic News Today
    • Business
    • Entertainment
    • Lifestyle
    • National
    • Technology
    • Education
    Republic News Today
    Home»Health»Renowned Cardiologist Dr Luca Testa Highlights the Effectiveness of Abluminus DES+ in Complex Angioplasty Cases
    Health

    Renowned Cardiologist Dr Luca Testa Highlights the Effectiveness of Abluminus DES+ in Complex Angioplasty Cases

    By July 10, 2023No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    Faridabad/Aligarh [India], July 10: Dr Luca Testa, a renowned interventional cardiologist at IRCCS Policlinico San Donato – Milan, Italy, has successfully conducted a series of educational workshops on the effectiveness of Abluminus DES+ in complex percutaneous coronary intervention. These workshops, organized by Concept Medical as part of their educational initiative, showcased the superior capabilities of Abluminus DES+ in treating complex lesions and diffuse disease in angioplasty.

    The first workshop was held on 3rd July 2023 at Jawaharlal Nehru Medical College and Hospital (Aligarh Muslim University) in collaboration with Dr Asif Hasan and Dr Azharuddin Malik. The second workshop took place on 4th July 2023 at Fortis Escorts Hospital, Faridabad, with the participation of Dr Sanjay Kumar alongside Dr. Luca Testa.

    Dr. Luca Testa expressed his satisfaction with the outcomes achieved using Abluminus DES+ in all the workshops conducted in various Indian institutions. The cases involved patients with complex coronary disease, including chronic total occlusions (CTOs) and severe in-stent restenosis.

    “Abluminus DES+ has been my choice of stent for many years, particularly in complex cases, and the results have been promising,” stated Dr. Luca Testa during a press conference. “This unique combination of a drug-coated balloon and a bioresorbable polymer sirolimus-eluting stent offers distinct advantages, especially when treating complex and diffuse disease. It is noteworthy that interventional cardiology is undergoing a significant paradigm shift. Despite the availability of advanced DES technologies like Abluminus DES+, we are progressively changing our approach, considering alternative options such as the Sirolimus-coated balloon Magic Touch. I firmly believe that in the future, we will witness a further implementation of drug-coated balloon technology in our daily practice, either alongside or even independently of stent usage. Abluminus is undoubtedly one of the finest technologies available, especially for complex cases.”

    Dr. Luca Testa’s workshops have provided valuable insights into the efficacy and potential of Abluminus DES+ in complex angioplasty procedures. With these educational initiatives, Concept Medical and Dr Testa aim to enhance the knowledge and expertise of healthcare professionals in India, ultimately leading to improved patient outcomes and advancing the field of interventional cardiology.

    Explaining the innovation, Concept Medical’s Founder & MD, Dr Manish Doshi, said, “In several patients with type II diabetes and coronary heart disease, there is as recurrence of major adverse cardiac events (MACE) like heart attack, stroke and restenosis (narrowing of unblocked artery after operation). This abluminal drug-eluting stent DES+ will considerably reduce the chances of recurrence.”

    About Dr. Luca Testa:

    Dr. Luca Testa is a renowned interventional cardiologist at IRCCS Policlinico San Donato – Milan, Italy. With extensive experience in complex coronary interventions, Dr. Testa has been instrumental in the development and advancement of novel treatment options in the field of interventional cardiology.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    Health

    Related Posts

    ’70–80% of Medical Issues Don’t Need Hospitalization’ — Ashish Srivastava’s Visionary Day-Care Model

    July 13, 2026

    AI Progress in Healthcare: How Intelligent Technology Is Transforming Patient Care

    July 7, 2026

    You’re Not Deficient. Your Diet Just Has Gaps.

    July 1, 2026

    Comments are closed.

    Recent Posts
    • NVIDIA’s AI Crown Faces Challengers, Not A Collapse
    • AI’s Biggest Battle Is No Longer the Model—It’s the Machine
    • Shaping Legacy with Strategic Mastery: IIM Calcutta Launches 8th Batch of Family Business Management to Groom Next-Gen Leaders
    • How Visionary CEO Ketan Dave is Steering Mr. Idli Toward an Historic IPO and Global Dominance
    • IHH FutureHealth.Now 2026 Explores How Affordability, AI, and Precision Medicine Will Shape the Future of Care
    Search
    Recent Posts
    • NVIDIA’s AI Crown Faces Challengers, Not A Collapse
    • AI’s Biggest Battle Is No Longer the Model—It’s the Machine
    • Shaping Legacy with Strategic Mastery: IIM Calcutta Launches 8th Batch of Family Business Management to Groom Next-Gen Leaders
    • How Visionary CEO Ketan Dave is Steering Mr. Idli Toward an Historic IPO and Global Dominance
    • IHH FutureHealth.Now 2026 Explores How Affordability, AI, and Precision Medicine Will Shape the Future of Care
    • PRSI Ahmedabad to Host National Conference on ‘Fact-Checking in the Age of AI’ on July 18

    Type above and press Enter to search. Press Esc to cancel.